FDA Says Its Safety Review of Abortion Pill Will Continue Into Next Year

(MedPage Today) -- The FDA says its ongoing safety review of mifepristone, the nation's main abortion pill, will continue into next year, a timeline that was quickly condemned by abortion opponents hoping to see the drug's use curtailed. The FDA...